Literature DB >> 3985076

Factors influencing the outcome of laser trabeculoplasty.

A Tuulonen, P J Airaksinen, K Kuulasmaa.   

Abstract

We applied multiple stepwise logistic regression analysis to the preoperative data for 153 glaucomatous patients to determine the predictive value of different variables in the outcome of laser trabeculoplasty. One hundred patients had capsular glaucoma and 53 patients had simple glaucoma. Of the 14 preoperative variables included in the analysis, the following best predicted successful outcome of the laser treatment: laser trabeculoplasty performed as primary therapy, low maximum pretreatment intraocular pressure, a diagnosis of capsular glaucoma, no preoperative treatment with pilocarpine, and the operator's experience with the procedure. Age, sex, pigmentation of the angle, the energy level used, the number of burns, the use of preoperative medication other than pilocarpine, and the occurrence of an immediate postoperative increase in intraocular pressure could not be shown to have predictive value as to the outcome of the treatment. Inclusion of postoperative follow-up period did not improve the model.

Entities:  

Mesh:

Year:  1985        PMID: 3985076     DOI: 10.1016/0002-9394(85)90002-9

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  3 in total

1.  Baseline IOP predicts selective laser trabeculoplasty success at 1 year post-treatment: results from a randomised clinical trial.

Authors:  W G Hodge; K F Damji; W Rock; R Buhrmann; A M Bovell; Y Pan
Journal:  Br J Ophthalmol       Date:  2005-09       Impact factor: 4.638

2.  The effect of argon laser trabeculoplasty on the blood-aqueous barrier and intraocular pressure in human glaucomatous eyes treated with diclofenac 0.1%.

Authors:  M Diestelhorst; D Thull; G K Krieglstein
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-09       Impact factor: 3.117

3.  Long-term efficacy of primary laser trabeculoplasty.

Authors:  T Elsås; H Johnsen
Journal:  Br J Ophthalmol       Date:  1991-01       Impact factor: 4.638

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.